Evidence map›Paper›PMID 40600172›Full record

ArticleJournal of oral microbiology2025

Enhanced dominance of nitrate-reducing bacteria using a combination of nitrate and erythritol in

Akihiko Fujii, Tomoki Akatsu, Hatsumi Souno, Sawako Kawano, Yoshihiko Minegishi, Noriyasu Ota

Abstract read
In one paragraph

Article in Journal of oral microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Akihiko FujiiHuman Health Care Products Research, Kao Corporation, Tochigi, Japan.ORCID https://orcid.org/0000-0003-3825-5263
Tomoki AkatsuHuman Health Care Products Research, Kao Corporation, Tochigi, Japan.
Hatsumi SounoHuman Health Care Products Research, Kao Corporation, Tochigi, Japan.
Sawako KawanoHuman Health Care Products Research, Kao Corporation, Tochigi, Japan.
Yoshihiko MinegishiHuman Health Care Products Research, Kao Corporation, Tochigi, Japan.
Noriyasu OtaR&D Strategy, Kao Corporation, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Oral nitrate-reducing bacteria are associated with good oral health, with inorganic nitrate specifically promoting the growth of these beneficial bacteria. Sugar alcohols affect the composition of oral microbiota, potentially impacting oral health. The present study aimed to investigate the combined effects of nitrate and sugar alcohols on nitrate-reducing bacteria and nitrate metabolism in oral microbiota cultured Methods: Species-level microbial analysis using 16S rRNA gene sequencing of DNA extracted from the supragingival plaque-derived biofilm cultured under micro-aerobic conditions for 48 h with nitrate and/or sugar alcohols was conducted. Nitrate metabolites, lactate, and pH in culture supernatants were also measured. Results: The combined addition of nitrate and erythritol, but not xylitol or sorbitol, significantly increased the relative abundance of Haemophilus parainfluenzae and Neisseria subflava, which are nitrate-reducing bacteria. This shift was accompanied by a corresponding decrease in Streptococcus oralis, which simultaneously induced an increase in the nitrate-reducing capacity and a decrease in lactate production and acidification from sugar metabolism. Conclusions: The combination of nitrate and erythritol serve as a preventive and therapeutic approach for periodontitis or dental caries by promoting the growth of oral commensal nitrate-reducing bacteria. However, human clinical studies are required to clarify these beneficial effects.

Indexed as

erythritolHaemophilusNeisseriaNitrateNitrate-reducing bacteriaoral microbiota

Identifiers

PMID40600172
PMCPMC12210410

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.